Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA455684
Max Phase: Preclinical
Molecular Formula: C14H12N2OS
Molecular Weight: 256.33
Molecule Type: Small molecule
Associated Items:
ID: ALA455684
Max Phase: Preclinical
Molecular Formula: C14H12N2OS
Molecular Weight: 256.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCC(=O)N1c2ccccc2Sc2ccccc21
Standard InChI: InChI=1S/C14H12N2OS/c15-9-14(17)16-10-5-1-3-7-12(10)18-13-8-4-2-6-11(13)16/h1-8H,9,15H2
Standard InChI Key: IIQVHKINCMEVON-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 256.33 | Molecular Weight (Monoisotopic): 256.0670 | AlogP: 2.77 | #Rotatable Bonds: 1 |
Polar Surface Area: 46.33 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.96 | CX LogP: 2.02 | CX LogD: 1.36 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.85 | Np Likeness Score: -0.88 |
1. Podust LM, von Kries JP, Eddine AN, Kim Y, Yermalitskaya LV, Kuehne R, Ouellet H, Warrier T, Alteköster M, Lee JS, Rademann J, Oschkinat H, Kaufmann SH, Waterman MR.. (2007) Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography., 51 (11): [PMID:17846131] [10.1128/aac.00311-07] |
Source(1):